Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Post by jfogarty12on May 14, 2020 8:22am
167 Views
Post# 31026405

People were wondering Why with this one --

People were wondering Why with this one --Aleafia notches $6.4M in positive adjusted EBITDA in Q1 amid low production costs 

Aleafia Health reported first-quarter results on Wednesday, recording $6.4 million of positive adjusted EBITDA on $13.7 million in revenue. The Toronto-based company is now just a handful of Canadian cannabis producers that has demonstrated consistent positive cash flow in its business. Aleafia also noted it has about $35 million in cash on its balance sheet and a production cost of $0.35 per gram, an industry low. The company is also managing its operations during the COVID-19 pandemic by conducting its medical cannabis consultations virtually, and introduced a delivery service to its patients. 
<< Previous
Bullboard Posts
Next >>